Ashley Gallagher is an assistant editor at Pharmacy Times®. She graduated from St. Bonaventure University in 2020 in journalism and mass communications. Previously, she worked as a pharmacy technician for a retail chain.
Pharmacy Focus: Limited Series - Celebrity Endorsements in Vaccine Hesitancy
March 6th 2024This episode highlights how celebrity endorsements and local influencers can be leveraged to address vaccine hesitancy by shaping attitudes, but also must account for factors like audience trust and the potential for both benefits and limitations.
Read More
AAO-HNSF Publishes Clinical Practice Guidelines for Allergen Immunotherapy
March 4th 2024AAO-HNSF guideline development group included 17 panel members, including experts from otolaryngology and allergy, those who have knowledge in clinical practice guideline development, and patient representatives.
Read More
FDA Grants Breakthrough Therapy Designation to NVL-520 for ROS1-Positive NSCLC
February 28th 2024NVL-520 is a novel brain-penetrant ROS1-selective TKI being investigated for ROS1-positive metastatic non–small cell lung cancer in patients who have previously been treated with 2 or more ROS1 TKIs.
Read More
FDA Accepts Supplemental New Drug Application for Adagrasib for Colorectal Cancer
February 26th 2024The sNDA was based on results from the KRYSTAL-1 study, evaluating the drug alone or in combination with other anti-cancer therapies in those with advanced solid tumors who have KRASG12C mutations.
Read More